Editorial: Community Series in Tumor Microenvironment and Metabolic Reprogramming in Cancer: Volume II - Top-Institutions - MDSpire

Editorial: Community Series in Tumor Microenvironment and Metabolic Reprogramming in Cancer: Volume II

  • By

  • Sang, Yaodong

  • Gao, Huanyu

  • Li, Jingsi

  • Raza, Asif

  • Zhu, Houjuan

  • Cui, Xiaoling

  • Wei, Yiju

  • Chen, Hao

  • Chong, Wei

  • June 3, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Tumor Microenvironment
    • Cancer Metabolism

  • #2

    Memorial Sloan Kettering Cancer Center (MSK)
    Memorial Sloan Kettering Cancer Center (MSK)

    New York, New York

    Key Differentiators

    • Oncology
    • Tumor Microenvironment
    • Cancer Metabolism

  • #3

    Chan Soon-Shiong Institute of Molecular Medicine
    Chan Soon-Shiong Institute of Molecular Medicine

    Los Angeles, California

    Key Differentiators

    • Molecular Medicine
    • Oncology

  • #4

    University of California, Los Angeles (UCLA)
    University of California, Los Angeles (UCLA)

    Los Angeles, California

    Key Differentiators

    • Oncology
    • Cancer Research

  • #5

    Imperial College of London
    Imperial College of London

    London, England

    Key Differentiators

    • Oncology
    • Medical Research

Original Source(s)

Editorial: Community Series in Tumor Microenvironment and Metabolic Reprogramming in Cancer: Volume II

  • by Sang, Yaodong , Gao, Huanyu , Li, Jingsi , Raza, Asif , Zhu, Houjuan , Cui, Xiaoling , Wei, Yiju , Chen, Hao , Chong, Wei

  • June 3, 2026

Related Content

Correction: Stereotactic radiotherapy for brain metastases: indications, dose fractionation, technological innovations, and evolving combination strategies – a comprehensive review

Neural regulation of tumor progression: implications for hepatocellular carcinoma

2026 AACR Prostate Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from AACR 2026.

  • June 17, 2026

  • 1 min